Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH2 | P25021 | 1/20 | 0.41 |
| ▸ | HRH1 | P35367 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.41 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.41 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.41 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | PDCD1 | Q15116 | 2/20 | 0.30 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.30 |
| ▸ | DRD2 | P14416 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27393425 | 1.00 | HRH2 (0.41) | HRH2HRH1HRH3S1PR1S1PR3 | |
| SCHEMBL30598272 | 1.00 | HRH2 (0.41) | HRH2HRH1HRH3S1PR1S1PR3 | |
| SCHEMBL30598302 | 0.88 | S1PR4 (0.36) | HRH2HRH1HRH3S1PR1S1PR3 | |
| SCHEMBL29646170 | 0.88 | S1PR4 (0.36) | HRH2HRH1HRH3S1PR1S1PR3 | |
| SCHEMBL30598274 | 0.88 | S1PR4 (0.36) | HRH2HRH1HRH3S1PR1S1PR3 | |
| SCHEMBL4550235 | 0.86 | KDM4E (0.43) | S1PR1S1PR3S1PR5S1PR4KDM4E | |
| SCHEMBL23168673 | 0.84 | S1PR1 (0.59) | HRH2HRH1HRH3S1PR1S1PR3 | |
| SCHEMBL18618225 | 0.82 | — | — | |
| SCHEMBL8442623 | 0.82 | — | — | |
| SCHEMBL4550233 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023171736-A1 | MEDICINE CONTAINING VITAMIN D DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, USED IN COMBINATION WITH IMMUNOMODULATORY SUBSTANCE | 帝人ファーマ株式会社 | 2023-09-14 | — | — | WO | disclosed |
| WO-2023006019-A1 | POLYSUBSTITUTED BENZENE PD-L1 INHIBITOR, COMPOSITION AND USE THEREOF | 杭州和正医药有限公司 | 2023-02-02 | — | — | WO | disclosed |